What question did this study set out to answer?

This research evaluates the cost-effectiveness of 18F-choline PET/CT compared to MIBI SPECT/CT for localization in primary hyperparathyroidism (PHPT).

February 26, 2026

Cost-Effectiveness of 18F-Choline PET/CT Versus MIBI SPECT/CT for Preoperative Localization in Primary Hyperparathyroidism in the Colombian Healthcare System.

Key Points

This research evaluates the cost-effectiveness of 18F-choline PET/CT compared to MIBI SPECT/CT for localization in primary hyperparathyroidism (PHPT).
Cost-effectiveness analysis comparing 18F-choline PET/CT and MIBI SPECT/CT
Focus on preoperative localization in patients with primary hyperparathyroidism
Assessment within the Colombian healthcare system
18F-choline PET/CT demonstrated cost-effectiveness over MIBI SPECT/CT
Findings support selective adoption of 18F-choline PET/CT in diagnostic algorithms
Results inform healthcare policy decisions in Colombia

Abstract

18F-choline PET/CT is a clinically useful and cost-effective strategy for preoperative localization in PHPT compared with MIBI-SPECT/CT. These findings support its selective adoption in diagnostic algorithms and inform healthcare policy decisions.

Perguntar à IA

Bookmark